Marlene Panzer, Eva Meindl, Benedikt Schaefer, Sonja Wagner, Bernhard Glodny, Gert Mayer, Andreas Pircher, Christoph Schwarz, Felix Beckmann, Clivia Hejny, Bastian Joachim-Mrosko, Juergen Konzett, Herbert Tilg, Isabel Heidegger, Myles Wolf, Ralf Weiskirchen, Heinz Zoller
Patients with Crohn's disease are at increased risk for symptomatic nephrolithiasis. Stones in these patients are most commonly composed of calcium oxalate monohydrate or mixed calcium-oxalate and calcium-phosphate. Precipitation of both minerals depends on urinary pH, calcium, phosphate and oxalate excretion. The present manuscript reports on two patients with Crohn's disease and bowel resection, in whom the onset of symptomatic urolithiasis occurred after repeated infusions of ferric carboxymaltose - a drug, which is known to cause hyperphosphaturia...
June 2024: Bone Reports